<p><sup>##</sup> represents the statistical significance vs. control group; **represents the statistical significance vs. diabetes model, n = 6 to 8.</p
<p>(A) Blood glucose levels were measured in overnight-fasted female <i>db/db</i> mice (n = 9–10 per...
<p>BDDE was administered orally to db/db mice once a day for 4 weeks. The blood glucose (A), HbA1c l...
<p>A: body weight of the mice during treatment in each group. B: body weight gain of the mice during...
<p><sup>##</sup>represents statistical significance vs. control group; **represents statistical sign...
<p>(A) A significant increase in MDA level was observed in diabetic mice, which was reduced by THSG....
<p>Fasting blood glucose and body weight were measured before THSG treatment and after THSG was admi...
<p>(A) Blood glucose levels in vehicle- and empagliflozin-treated (3mg/kg for 8 days) mice during an...
<p>The body weight (A) and blood glucose levels (B) of C57BL/6 mice were measured once a week. Blood...
<p>OGTT time course and AUC in normal mice (A, B), HFD/STZ mice (C, D) and <i>db/db</i> mice (E, F)....
<p>(A, D) No significant change was observed on blood glucose levels during the OGTT between vehicle...
<p>A: gastrocnemius weight of the mice during treatment in each group. B: quadriceps weight of the m...
<p>Mice received the indicated sample treatments for 5 weeks. Diabetes was induced by multiple (for ...
<p>A: FPE decreased blood glucose in the experimental diabetic mice. B: FPE increased body weights i...
<p>Empagliflozin reduced insulin requirement in diabetic mice (B). The comparison was made between a...
<p>Data are mean±SD, n = 10–18, **p<0.01 compared with non-diabetic WT or KO mice.</p><p>Blood gluco...
<p>(A) Blood glucose levels were measured in overnight-fasted female <i>db/db</i> mice (n = 9–10 per...
<p>BDDE was administered orally to db/db mice once a day for 4 weeks. The blood glucose (A), HbA1c l...
<p>A: body weight of the mice during treatment in each group. B: body weight gain of the mice during...
<p><sup>##</sup>represents statistical significance vs. control group; **represents statistical sign...
<p>(A) A significant increase in MDA level was observed in diabetic mice, which was reduced by THSG....
<p>Fasting blood glucose and body weight were measured before THSG treatment and after THSG was admi...
<p>(A) Blood glucose levels in vehicle- and empagliflozin-treated (3mg/kg for 8 days) mice during an...
<p>The body weight (A) and blood glucose levels (B) of C57BL/6 mice were measured once a week. Blood...
<p>OGTT time course and AUC in normal mice (A, B), HFD/STZ mice (C, D) and <i>db/db</i> mice (E, F)....
<p>(A, D) No significant change was observed on blood glucose levels during the OGTT between vehicle...
<p>A: gastrocnemius weight of the mice during treatment in each group. B: quadriceps weight of the m...
<p>Mice received the indicated sample treatments for 5 weeks. Diabetes was induced by multiple (for ...
<p>A: FPE decreased blood glucose in the experimental diabetic mice. B: FPE increased body weights i...
<p>Empagliflozin reduced insulin requirement in diabetic mice (B). The comparison was made between a...
<p>Data are mean±SD, n = 10–18, **p<0.01 compared with non-diabetic WT or KO mice.</p><p>Blood gluco...
<p>(A) Blood glucose levels were measured in overnight-fasted female <i>db/db</i> mice (n = 9–10 per...
<p>BDDE was administered orally to db/db mice once a day for 4 weeks. The blood glucose (A), HbA1c l...
<p>A: body weight of the mice during treatment in each group. B: body weight gain of the mice during...
DOI
Add to ORKG